Prevalence of Gram-negative bacteria harboring blaKPC gene in Colombian hospitals;Prevalencia de bacterias Gram negativas portadoras del gen blaKPC en hospitales de Colombia

Biomedica

Volumn 34, Issue SUPPL.1, 2014, Pages 81-90

  Pacheco, Robinson ^a   Osorio, Lyda ^a,b   Correa, Adriana M ^a   Villegas, María Virginia ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Cross infection,Colombia; Drug resistance,bacterial; Gram negative bacteria,prevalence

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CHILD; CLINICAL TRIAL; COLOMBIA; CROSS INFECTION; CROSS-SECTIONAL STUDY; ENZYMOLOGY; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL; HUMAN; INFANT; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PHENOTYPE; PREVALENCE;

ADOLESCENT; ADULT; AGED; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; COLOMBIA; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, URBAN; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 84907365143     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v34i0.1642     Document Type: Article

References (29)

1. Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist. 2006;12:223-30. http://dx.doi.org/10.1089/mdr. 2006.12.223
2. Jones RN. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: A five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med. 2003;24:121-34. http://dx.doi.org/1010.1055/s-2003-37923
3. Walsh TR. Clinically significant carbapenemases: An update. Curr Opin Infect Dis. 2008;21:367-71. http://dx.doi.org/10.1097/QCO.0b013e328303670b
4. Villegas MV, Blanco MG, Sifuentes-Osornio J, Rossi F. Increasing prevalence of extended-spectrum-beta-lactamase among Gram-negative bacilli in Latin America-2008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Braz J Infect Dis. 2011;15:34-9. http://dx.doi.org/10.1590/S1413-86702011000100007
5. Briceño DF, Correa A, Valencia C, Torres JA, Pacheco R, Montealegre MC, et al. Actualización de la resistencia a los antimicrobianos de bacilos Gram negativos aislados en hospitales nivel III de Colombia, años 2006, 2007 y 2008. Biomedica. 2010;30:371-81.
6. Tafur JD, Torres JA, VIllegas MV. Mecanismos de resistencia a los antibióticos en bacterias Gram negativas. Infectio. 2008;12:217-26.
7. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54: 969-76. http://dx.doi.org/10.1128/AAC.01009-09
8. KPC-2 gene. Emerg Infect Dis. 2010;16:1349-56. http://dx.doi.org/10. 3201/eid1609.091389
9. Suárez CJ, Kattan JN, Guzmán AM, VIllegas MV. Mecanismos de resistencia a carbapenems en P. aeruginosa, Acinetobacter y Enterobacteriaceae y estrategias para su prevención y control. Infectio. 2006;10:85-93.
10. Maya JJ, Ruiz SJ, Blanco VM, Gotuzzo E, Guzmán-Blanco M, Labarca J, et al. Currents status of carbapenemases in Latin America. Expert Rev Anti Infect Ther. 2013;11:657-67. http://dx.doi.org/10.1586/14787210.2013.811924
11. KPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother. 2009;53:1998-2004. http://dx.doi.org/10.1128/AAC.01355-08
12. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother. 2008;52:1257-63. http://dx.doi.org/10.1128/AAC. 01451-07
13. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: Clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53:3365-70. http://dx.doi.org/10.1128/AAC.00126-09
14. Villegas MV, Lolans K, Correa A, Suárez CJ, López JA, Vallejo M, et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006;50:2880-2. http://dx.doi.org/1010. 1128/AAC.00186-06
15. Livermore DM. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs. 2002;3:218-24.
16. Yigit H, Queenan AM, Anderson GJ, Domenech-Sánchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151-61. http://dx.doi.org/10.1128/AAC. 45.4.1151-1161.2001
17. Villegas MV, Lolans K, Correa A, Kattan JN, López JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007;51:1553-5. http://dx.doi.org/10.1128/AAC.01405-06
18. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium. Arch Intern Med. 2005;27:1430-5. http://dx.doi.org/10.1001/archinte.165.12.1430
19. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and recommendations for detection. Antimicrob Agents Chemother. 2005;49:3018-20. http://dx.doi.org/10.1128/AAC. 49.7.3018-3020.2005
20. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228-36. http://dx.doi.org/10.1016/S1473-3099(09)70054-4
21. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R. BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother. 2008;62 (Suppl 2):ii41-54. http://dx.doi.org/10. 1093/jac/dkn351
22. Dortet L, Radu I, Gautier V, Blot F, Chachaty E, Arlet G. Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J Antimicrob Chemother. 2008;61:455-7. http://dx.doi.org/10.1093/jac/dkm455
23. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother. 2005;49:4423-4. http://dx.doi.org/10.1128/AAC. 49.10.4423-4424.2005
24. Lee K, Kim CK, Yong D, Jeong SH, Yum JH, Seo YH, et al. Improved performance of Modified Hodge test with Mac Conkey agar 250 for screening of carbapenemase - producing Gram-negative bacilli. J Microbiol Methods. 2010;32:149-52. http://dx.doi.org/10.1016/j.mimet.2010.08.010
25. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, eighteenth informational supplement. Wayne: CLSI; 2008.
26. Dice LR. Measures of the amount of ecological association between species. Ecology. 1945;26:297-302.
27. Tenover FC, Arbeit RD, Goering RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: A review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1997;18:426-39.
28. Stelling JM, O'Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis. 1997;24:157-68. http://dx.doi.org/10.1093/clinids/24.Supplement_1.S15
29. Mojica MF, Correa A, Vargas DA, Maya JJ, Montealegre MC, Rojas LJ, et al. Molecular correlates of the spread of KPC-producing Enterobacteriacea in Colombia. Int J Antimicrob Agents. 2012;40:277-9. http://dx.doi.org/10. 1016/j.ijantimicag.2012.05.006